This earnings season is likely to be more volatile than the market is preparing for, according to Goldman Sachs, which outlined a tactical plan for clients looking to play the latest financial numbers. » Read More
J.P. Morgan reiterates its overweight rating for MGM Resorts shares, predicting the company's earnings growth will improve next year. » Read More
Piper Jaffray reiterates its overweight rating for Lumentum shares, predicting strong growth for its products later this year. » Read More
Jefferies raises its rating for MSG shares to buy from hold on Wednesday, citing the rising value of the New York Knicks and Rangers. » Read More
IBM’s cloud, analytics and security segments should easily offset declines in its legacy business and present a buying opportunity for investors looking for sustainable revenue growth.
BTIG raises its rating to buy from neutral for Yum Brands shares.
Credit Suisse reiterates its outperform rating for Intel shares, predicting the chipmaker will generate strong earnings results next year.
Nomura Instinet reiterates its buy rating for Square shares, predicting the payment company's new offering "Square for Restaurants" will thrive.
J.P. Morgan reiterates its overweight rating for Cisco shares, predicting the company's recently announced mandatory subscription offering for switches will boost its profits.
Investors should expect strength in semiconductor equipment manufacturers through 2019, according to J.P. Morgan.
Five Below is set for years of solid income growth and stock appreciation thanks to new store openings, according to J.P. Morgan.
Morgan Stanley shares with clients its top stock picks.
UBS shares with clients its top stock picks.
The hot trade in aerospace and defense – including that of industry leader Raytheon – is coming to an end, according to Credit Suisse.
Analyst Itay Michaeli believes the automaker's shares could nearly double to $70 over the next 12 months
Morgan Stanley revealed its 30 best long-term stock picks on Wednesday, predicting choppy, range-bound equity trading at the index level to come.
There are still many stocks on Wall Street that have yet to receive the attention from investors they deserve, according to Credit Suisse.
Goldman Sachs gives its best biotech stock picks.
Investors should position their portfolios for a big infrastructure bill in the coming years, according to Morgan Stanley.